B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

NUCLEAR

MOLECULAR TARGET

Nuclear factor erythroid 2-related factor 2 (human)

UniProt: Q16236162 compounds

NUCLEAR (Nuclear factor erythroid 2-related factor 2 (human)) is targeted by 162 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting NUCLEAR

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1alyssin [Supplementary Concept]3.1823
2Dimethyl Fumarate2.4010
3Resveratrol2.087
4cycloheximide1.956
5Estrone1.956
6Thiabendazole 2-Substituted benzimidazole first introduced in 1962. It is active against1.956
7Methylene Blue1.795
8Methotrexate1.795
9Clotrimazole1.795
10dimethyl formamide1.795
11Dimethylformamide1.795
12Ethinyl Estradiol1.795
13Hydrocortisone1.795
14Niclosamide1.795
15Progesterone1.614
16Bromodeoxyuridine1.614
17Carboxin1.614
18Cladribine1.614
19Colchicine1.614
20Digoxin1.614
21Ethoxyquin Antioxidant; also1.614
22Fenofibrate1.614
23fluoranthene1.614
24Hexachlorophene1.614
25Cervugid [Supplementary Concept]1.614
26Leflunomide1.614
27Linuron1.614
28Mestranol1.614
29Phenoxybenzamine1.614
30Piperonyl Butoxide1.614
31vinblastine sulfate1.614
32Carbaryl1.393
33Corticosterone1.393
34Digitoxin1.393
35Digoxigenin 3 beta,12 beta,14-Trihydroxy-5 beta-card-20(22)-enolide.1.393
36Disulfiram1.393
37Ethidium1.393
38Melphalan1.393
39Methoxsalen1.393
40Nisoldipine1.393
41Phenelzine1.393
42Reserpine1.393
43Rotenone1.393
44Triamcinolone1.393
45Vincamine1.393
46Melatonin1.102
47Prednisolone1.102
482-Acetylaminofluorene1.102
49alsterpaullone1.102
50amlexanox1.102

Showing top 50 of 162 compounds. Use the BiohacksAI search to explore all NUCLEAR modulators.

About NUCLEAR as a Drug Target

NUCLEAR (Nuclear factor erythroid 2-related factor 2 (human)) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 162 compounds with documented NUCLEAR interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

NUCLEAR inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.